Elsevier

The Lancet Rheumatology

Volume 2, Issue 8, August 2020, Pages e457-ee458
The Lancet Rheumatology

Correspondence
Canakinumab in a subgroup of patients with COVID-19

https://doi.org/10.1016/S2665-9913(20)30167-3Get rights and content

Cited by (0)

View Abstract